These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15288829)

  • 21. Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT.
    Adamietz IA; Baum RP; Schemman F; Niesen A; Knecht R; Saran F; Tieku S; Boniface GR; Hör G; Böttcher HD
    J Nucl Med; 1996 Dec; 37(12):1942-6. PubMed ID: 8970510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunolocalization of primary and metastatic breast cancer.
    Baum RP; Brümmendorf TH
    Q J Nucl Med; 1998 Mar; 42(1):33-42. PubMed ID: 9646643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
    Brink I; Klenzner T; Krause T; Mix M; Ross UH; Moser E; Nitzsche EU
    Nuklearmedizin; 2002 Apr; 41(2):108-13. PubMed ID: 11989297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.
    Quak J; Gerretsen M; De Bree R; Brakenhof R; Van Dongen G; Snow G
    Anticancer Res; 1993; 13(6B):2533-9. PubMed ID: 8135493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
    Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
    Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
    Larson SM
    Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
    Peña Y; Perera A; Batista JF
    MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
    Kutler DI; Wong RJ; Schoder H; Kraus DH
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
    Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
    Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project.
    Timon CI; McShane D; Hamilton D; Walsh MA
    J Otolaryngol; 1991 Aug; 20(4):283-7. PubMed ID: 1920585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
    Rosanowski F; Briele B; Walther EK
    Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
    McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
    Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
    Zalutsky MR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1958-60. PubMed ID: 16609003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.